The medical management of rhinosinusitis.
The management of rhinosinusitis depends on a number of variables related to the duration and severity of symptoms in the individual patient. Furthermore acute rhinosinusitis is managed differently than chronic rhinosinusitis. Because a variety of conservative and pharmacologic interventions are available, the physician can find it difficult to develop a cohesive and logical approach to treatment. An understanding of the pathophysiology, microbiology, and natural history of rhinosinusitis is necessary to formulate the best treatment plan for the individual patient.
Benninger
M S
MS
Department of Otolaryngology-Head and Neck Surgery, Henry Ford Hospital, Detroit, MI 48202, USA.
Anon
J
J
Mabry
R L
RL
D000208:Acute Disease; D000287:Administration, Topical; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002908:Chronic Disease; D005938:Glucocorticoids / Q000627:therapeutic use; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D014663:Nasal Decongestants / Q000627:therapeutic use; D012220:Rhinitis / Q000145:classification / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D012720:Severity of Illness Index; D012852:Sinusitis / Q000145:classification / Q000188:drug therapy* / Q000382:microbiology / Q000503:physiopathology; D013290:Streptococcal Infections / Q000188:drug therapy; D013296:Streptococcus pneumoniae; D013997:Time Factors
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D006634:Histamine H1 Antagonists; D014663:Nasal Decongestants